TBS子宫颈细胞学报告系统回顾及新版解读

发布时间：2018-03-24 20:08

本文选题：TBS　切入点：鳞状上皮内病变　出处：《中国妇产科临床杂志》2017年01期

【摘要】：正TBS(The Bethesda System)子宫颈细胞学报告系统的应用已经走过近30年的历程,其发生和发展对子宫颈细胞学乃至妇科临床都产生了深远的影响。一、TBS报告系统的历史回顾TBS报告系统创立于1988年,经过了两次改进(TBS-1991,RBS-2001)。其目的是建立能够提供明确管理阈值和减少观察者间差异的报告术语。TBS-1988报告系统确定了对标本满意度评估这一重要的标本质量保证内容,并推荐对于鳞状上皮内病变(SIL)的2级分类报告术语,即:低级别
[Abstract]:The application of positive TBS(The Bethesda system in cervical cytology report system has gone through nearly 30 years. Its occurrence and development have had a profound impact on cervical cytology and gynecologic clinic. The history of TBS reporting system was established in 1988. Two improvements have been made to TBS-1991 / RBS-2001.The aim is to establish a reporting system that provides clear management thresholds and reduces inter-observer differences. The TBS-1988 reporting system identifies an important quality assurance element for specimen satisfaction assessment. We also recommend the level 2 classification reporting terms for squamous intraepithelial lesions, I. e.
【作者单位】：中国医学科学院肿瘤医院;

【相似文献】